Abstract
Two mathematical approaches are described to approximate the distribution of compounds (e.g., drugs) in the cerebrospinal fluid (CSF) downstream of or distal to both the ventricular injection site and the cisterna magna sampling site. The first approach uses a graphic representation and is, in essence, model independent;the second approach considers the geometry and physiology of CSF distribution and clearance. In all studies, radiolabeled inulin was used as an “internal standard” since it is not metabolized and is eliminated from the CSF primarily by bulk flow. Temporal comparison of the study compound to radiolabeled inulin in the cisternal CSF allowed testing of these models in beagle dogs. One use of this data is in the estimation of the drug exposure integral for antineoplastic drugs administered in the CSF to treat leptomeningeal neoplasia.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Abbreviations
- CSF:
-
cerebrospinal fluid
- ICSF:
-
intracerebrospinal fluid
- DFMO:
-
α-difluoromethylornithine
- MGBG:
-
methylglyoxal bis(guanylhydrazone)
- ACNU:
-
3-[(4-amino-2-methyl-5-pyrimidinyl)-ethyl]-1-(2-chloroethyl)-1-nitrosourea
References
H. Davson.Physiology of the Cerebrospinal Fluid, Churchill, London, 1967.
R. G. Blasberg, C. S. Patlak, and W. R. Shapiro. Distribution of methotrexate in the cerebrospinal fluid and brain after intraventricular administration.Cancer Treat. Rep. 61:633–641 (1977).
H. F. Cserr, J. D. Fenstermacher, and V. Fencl (eds).Fluid Environment of the Brain, Academic Press, New York, 1975.
W. W. Oppelt, T. H. Maren, E. S. Owens, and D. P. Rall. Effects of acid-base alterations on cerebrospinal fluid production.Proc. Soc. Exp. Biol. Med. 114:86–89 (1963).
S. I. Rapoport.Blood-Brain Barrier in Physiology and Medicine, Raven Press, New York, 1976.
H. F. Cserr. Physiology of the choroid plexus.Physiol. Rev. 51:273–311 (1971).
R. G. Blasberg, C. Patlak, and J. D. Fenstermacher. Intrathecal chemotherapy: Brain tissue profiles after ventriculo-cisternal perfusion.J. Pharmacol. Exp. Ther. 195:73–83 (1975).
C. S. Patlak and J. D. Fenstermacher. Measurements of dog blood-brain transfer constants by ventriculocisternal perfusion.Am. J. Physicol. 229:877–884 (1975).
J. D. Fenstermacher, R. G. Blasberg, and C. S. Patlak. Methods for quantifying the transport of drugs across brain barrier systems.Pharmacol. Ther. 14:217–248 (1981).
J. D. Fenstermacher, D. P. Rall, C. S. Patlak, and V. A. Levin. Ventriculocisternal perfusion as a technique for analysis of brain capillary permeability and extracellular transport. InAlfred Benzon Symposium on Capillary Permeability Munksgaard, Copenhagen, 1969, pp. 483–490.
J. D. Fenstermacher, L. C. Liu, and V. A. Levin. Extracellular space of the cerebral cortex of normothermic and hypothermic cats.Exp. Neurol. 27:101–114 (1970).
V. A. Levin, J. D. Fenstermacher, and C. S. Patlak, Sucrose and inulin space measurements of cerebral cortex in four mammalian species.Am. J. Physiol. 219:1528–1533 (1970).
J. D. Fenstermacher, C. S. Patkal, and R. G. Blasberg. Transport of material between brain extracellular fluid, brain cells and blood.Fed. Proc. 33(9):2070–2073 (1974).
E. A. Bering and O. Sato. Hydrocephalus: Changes in formation and absorption of cerebrospinal fluid within the cerebral ventricles.J. Neurosurg. 20:1050–1063 (1963).
V. A. Levin, T. H. Milhorat, J. D. Fenstermacher, M. K. Hammock, and D. P. Rall. Physiological studies on the development of obstructive hydrocephalus in the monkey.Neurology 21:238–246 (1971).
V. A. Levin, J. Csejtey, and D. J. Byrd. Brain, CSF, and tumor pharmacokinetics of alpha-difluoromethylornithine in rats and dogs.Cancer Chemother. Pharmacol. 10:196–199 (1983).
V. A. Levin, D. Byrd, J. Campbell, R. L. Davis, and J. K. Borcich. CNS toxicity and CSF pharmacokinetics of intraventricular DFMO and MGBG in beagle dogs.Cancer Chemother. Pharmacol. 13:200–205 (1985).
V. A. Levin, D. J. Byrd, J. Campbell, D. D. Giannini, J. K. Borcich, and R. L. Davis. CNS toxicity and CSF pharmacokinetics of intraventricular 3-[(4-amino-2-methyl-5-pyrimidinyl)ethyl]-1-(2-chloroethyl)-1-nitrosourea and other nitrosoureas in beagle dogs.Cancer Res. 45:3803–3809 (1985).
M. G. Rosenblum, D. J. Stewart, B. S. Yap, M. Leavens, R. S. Benjamin, and T. L. Loo. Penetration of methylgSyoxal bis(guanylhydrazone) into intracerebrai tumors in humans.Cancer Res. 41:459–462 (1981).
L. Alhonen-Hongisto, P. Seppanen, and J. Janne. Intracellular putrescine and spermidine deprivation induces increased uptake of natural polyamines and methylglyoxal bis(guanyl-hydrazone).Biochem. J. 192:941–945 (1980).
V. A. Levin. Clinical pharmacology of nitrosoureas. In A. W. Prestayko and S. T. Crooke (eds.),Nitrosoureas: Current Status and New Developments, Academic Press, New York, 1981, pp. 171–180.
M. Gibaldi and D. Perrier.Pharmacokinetics, Dekker, New York, Vol. 1, 1975, pp. 45–83.
Author information
Authors and Affiliations
Additional information
This work was supported in part by HEW grants CA-30571 and CA-13525.
Rights and permissions
About this article
Cite this article
Levin, V.A., Landahl, H.D. Pharmacokinetic approaches to drug distribution in the cerebrospinal fluid based on ventricular administration in beagle dogs. Journal of Pharmacokinetics and Biopharmaceutics 13, 387–403 (1985). https://doi.org/10.1007/BF01061476
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01061476